268 related articles for article (PubMed ID: 25669623)
1. The urinary levels of prostanoid metabolites predict acute kidney injury in heterogeneous adult Japanese ICU patients: a prospective observational study.
Ujike-Omori H; Maeshima Y; Kinomura M; Tanabe K; Mori K; Watatani H; Hinamoto N; Sugiyama H; Sakai Y; Morimatsu H; Makino H
Clin Exp Nephrol; 2015 Dec; 19(6):1024-36. PubMed ID: 25669623
[TBL] [Abstract][Full Text] [Related]
2. Thromboxane and prostacyclin biosynthesis in patients with acute spontaneous intracerebral hemorrhage.
Saloheimo P; Juvela S; Riutta A; Pyhtinen J; Hillbom M
Thromb Res; 2005; 115(5):367-73. PubMed ID: 15733969
[TBL] [Abstract][Full Text] [Related]
3. Excretion of primary prostanoids and their metabolites during acute volume expansion.
Seyberth HW; Tulassay T; Kühl PG; Soeding K; Rascher W; Schweer H
Prostaglandins; 1988 Feb; 35(2):221-32. PubMed ID: 3163156
[TBL] [Abstract][Full Text] [Related]
4. Abnormal prostanoid metabolism in lupus nephritis and the effects of a thromboxane A2 synthetase inhibitor, DP-1904.
Yoshida T; Ichikawa Y; Tojo T; Homma M
Lupus; 1996 Apr; 5(2):129-38. PubMed ID: 8743126
[TBL] [Abstract][Full Text] [Related]
5. Biomarker Predictors of Adverse Acute Kidney Injury Outcomes in Critically Ill Patients: The Dublin Acute Biomarker Group Evaluation Study.
McMahon BA; Galligan M; Redahan L; Martin T; Meaney E; Cotter EJ; Murphy N; Hannon C; Doran P; Marsh B; Nichol A; Murray PT
Am J Nephrol; 2019; 50(1):19-28. PubMed ID: 31203271
[TBL] [Abstract][Full Text] [Related]
6. Urinary excretion of degradation products of prostacyclin and thromboxane is increased in patients with gestational choriocarcinoma.
Aitokallio-Tallberg AM; Jung JK; Kim SJ; Viinikka LU; Ylikorkala RO
Cancer Res; 1991 Aug; 51(16):4146-8. PubMed ID: 1868436
[TBL] [Abstract][Full Text] [Related]
7. Monitoring of the thromboxane A2/prostacyclin ratio in the urine of patients with retinal vascular occlusion through the low-dose-aspirin therapy using the gas chromatography/selected ion monitoring method.
Mizugaki M; Hishinuma T; Matsumura E; Murai Y; Yamazaki T; Yamanobe S; Tamai M
Prostaglandins Other Lipid Mediat; 1999 Nov; 58(5-6):253-62. PubMed ID: 10593167
[TBL] [Abstract][Full Text] [Related]
8. Which prostanoid metabolites should be determined for the study of reproductive processes?
van der Weiden RM; Helmerhorst FM; Keirse MJ
Prostaglandins Leukot Essent Fatty Acids; 1998 Mar; 58(3):205-7. PubMed ID: 9610843
[TBL] [Abstract][Full Text] [Related]
9. Desogestrel- and levonorgestrel-containing oral contraceptives have different effects on urinary excretion of prostacyclin metabolites and serum high density lipoproteins.
Ylikorkala O; Kuusi T; Tikkanen MJ; Viinikka L
J Clin Endocrinol Metab; 1987 Dec; 65(6):1238-42. PubMed ID: 2960690
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of clinically available renal biomarkers in critically ill adults: a prospective multicenter observational study.
Deng Y; Chi R; Chen S; Ye H; Yuan J; Wang L; Zhai Y; Gao L; Zhang D; Hu L; Lv B; Long Y; Sun C; Yang X; Zou X; Chen C
Crit Care; 2017 Mar; 21(1):46. PubMed ID: 28264714
[TBL] [Abstract][Full Text] [Related]
11. Urinary neutrophil gelatinase-associated lipocalin identifies critically ill young children with acute kidney injury following intensive care admission: a prospective cohort study.
Zwiers AJ; de Wildt SN; van Rosmalen J; de Rijke YB; Buijs EA; Tibboel D; Cransberg K
Crit Care; 2015 Apr; 19(1):181. PubMed ID: 25895828
[TBL] [Abstract][Full Text] [Related]
12. The change of urinary 11-dehydro-thromboxane B2 and 2,3-dinor-6-keto-prostaglandin F1 alpha in arteriogenic impotence.
Lin JS; Lui SM; Chen CM; Chang WC
J Urol; 1992 Aug; 148(2 Pt 1):311-3. PubMed ID: 1635125
[TBL] [Abstract][Full Text] [Related]
13. Serum Cystatin C as an Early Marker of Neutrophil Gelatinase-associated Lipocalin-positive Acute Kidney Injury Resulting from Cardiopulmonary Bypass in Infants with Congenital Heart Disease.
Herbert C; Patel M; Nugent A; Dimas VV; Guleserian KJ; Quigley R; Modem V
Congenit Heart Dis; 2015; 10(4):E180-8. PubMed ID: 25727405
[TBL] [Abstract][Full Text] [Related]
14. Increased thromboxane metabolites excretion in liver cirrhosis.
Davì G; Ferro D; Basili S; Iuliano L; Camastra C; Giammarresi C; Santarone S; Rocca B; Landolfi R; Ciabattoni G; Cordova C; Violi F
Thromb Haemost; 1998 Apr; 79(4):747-51. PubMed ID: 9569186
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of urine interleukin-18 in the evolution and outcome of acute kidney injury in critically ill adult patients.
Nisula S; Yang R; Poukkanen M; Vaara ST; Kaukonen KM; Tallgren M; Haapio M; Tenhunen J; Korhonen AM; Pettilä V;
Br J Anaesth; 2015 Mar; 114(3):460-8. PubMed ID: 25472925
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of urinary tissue inhibitor of metalloproteinase-2 in acute kidney injury: a prospective observational study.
Yamashita T; Doi K; Hamasaki Y; Matsubara T; Ishii T; Yahagi N; Nangaku M; Noiri E
Crit Care; 2014 Dec; 18(6):716. PubMed ID: 25524453
[TBL] [Abstract][Full Text] [Related]
17. Repulsive guidance cue semaphorin 3A in urine predicts the progression of acute kidney injury in adult patients from a mixed intensive care unit.
Doi K; Noiri E; Nangaku M; Yahagi N; Jayakumar C; Ramesh G
Nephrol Dial Transplant; 2014 Jan; 29(1):73-80. PubMed ID: 24166457
[TBL] [Abstract][Full Text] [Related]
18. Improvement of renal function with a selective thromboxane A2 synthetase inhibitor, DP-1904, in lupus nephritis.
Yoshida T; Kameda H; Ichikawa Y; Tojo T; Homma M
J Rheumatol; 1996 Oct; 23(10):1719-24. PubMed ID: 8895147
[TBL] [Abstract][Full Text] [Related]
19. Subclinical acute kidney injury is associated with adverse outcomes in critically ill neonates and children.
Fang F; Hu X; Dai X; Wang S; Bai Z; Chen J; Pan J; Li X; Wang J; Li Y
Crit Care; 2018 Oct; 22(1):256. PubMed ID: 30305134
[TBL] [Abstract][Full Text] [Related]
20. Determination of 6-keto-PGF1 alpha, 2,3-dinor-6-keto-PGF1 alpha, thromboxane B2, 2,3-dinor-thromboxane B2, PGE2, PGD2 and PGF2 alpha in human urine by gas chromatography-negative ion chemical ionization mass spectrometry.
Weber C; Höller M; Beetens J; De Clerck F; Tegtmeier F
J Chromatogr; 1991 Jan; 562(1-2):599-611. PubMed ID: 2026723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
